<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Molecular Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E192254A-182A-41E7-A6A9-E0892127BD83"><gtr:id>E192254A-182A-41E7-A6A9-E0892127BD83</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Knight</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E56CAE96-E8B2-4100-90AC-727DC450A92D"><gtr:id>E56CAE96-E8B2-4100-90AC-727DC450A92D</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Wilson</gtr:otherNames><gtr:surname>Ironside</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9"><gtr:id>23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900580"><gtr:id>305E7F55-C364-4F79-A53C-EB3037DD37CF</gtr:id><gtr:title>The NCJDSU Tissue Resource: support for continued banking activities</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900580</gtr:grantReference><gtr:abstractText>Prion diseases are fatal disorders that affect the brain, and include conditions such as BSE or ?mad cow disease? in cattle and Creutzfeldt-Jakob disease (CJD) in humans. One form of CJD, known as variant CJD, is linked to exposure to BSE through the diet. Prion diseases are transmissible, and studies of CJD and BSE have shown that the infectious agent accumulates at highest levels in the brain. However, the agent can also be present in a range of other tissues throughout the body. The aim of this research is to continue the collection and storage of tissues from all forms of CJD in a brain and tissue bank in the National CJD Surveillance Unit, Edinburgh. This bank played a key role in the discovery of variant CJD, and is in continuing use by a wide range of researchers in UK and across the world. The material collected comes from tissue and organs taken at autopsy from patients with suspected CJD only when the relatives have given consent. We also collect blood and CSF samples from living patients, again with consent. The bank has approval for this work from our local Ethical Committee, and has been used for many research projects, resulting in major scientific and medical publications. The information from this research has also made a big impact on the work of the NHS, particularly in steps to reduce the chance of transmission of variant CJD by blood transfusion and by surgical instruments. We believe that the bank will continue to be needed by researchers in the UK and elsewhere in the future, since there are so many unanswered questions about this group of diseases. There is also a major need to help develop a test for CJD that can be used on living patients, which will be helped by the use of the tissue and blood samples in our bank. We run the bank according to MRC guidelines, and use a Steering Committee (that includes 2 members of the public) to oversee our work. The results from our work are presented in many forms, such as scientific and medical papers, lectures (including public lectures) and in interviews with the press, radio and television.</gtr:abstractText><gtr:technicalSummary>This application seeks to renew MRC support for the National Creutzfeldt-Jakob Disease Surveillance Unit (NCJDSU) tissue resource (part of the MRC Edinburgh Brain Banks), in order to address research needs in the UK and overseas. Creutzfeldt-Jakob disease (CJD) is one of a group of fatal transmissible neurodegenerative disorders known as prion diseases. These disorders have reached enormous significance in UK since the epidemic of bovine spongiform encephalopathy (BSE) and the subsequent emergence of variant CJD (vCJD), which results from BSE infection in humans. The identification and characterisation of vCJD was critically dependent on the availability of a wide range of tissues, blood, cerebrospinal fluid and DNA and in a variety of forms (fixed, frozen etc) from the tissue resource in the NCJDSU. This resource is recognised as a unique collection and has been used by all the leading research groups in the field on a worldwide basis. The continuing uncertainties over the incidence of vCJD infection in the UK population, the tissue distribution of infectivity in all forms of human prion disease, the need to study the strains of the infectious agent in human prion disease and to understand the mechanisms of disease pathogenesis all reinforce the requirement for well characterised tissues that are available in a range of forms to maximise potential research use. The demands for materials in the NCJDSU tissue resource are not confined to vCJD, and encompass all forms of human prion disease (except kuru). The support requested is modest and comprises one technical post, support for two new freezer and consumables to cover running costs. The infrastructure of NCJDSU (funded by the Department of Health) allows a range of backup facilities (e.g. computer support, staff cover, tissue processing facilities) that allow this to be a cost-effective application. The NCJDSU tissue resource has LREC approval to store and use autopsy tissues for research purposes, and operates with governance, strategic oversight and advice on resource allocation from a Steering Committee on which MRC is represented. Data arising from research performed materials from the NCJDSU resource has generated a large quantity of publications in leading scientific and medical journals, and has provided considerable input to policy formulation and risk assessment in the UK and overseas. These important activities will be not only maintained, but strengthened by this application.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>186637</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Neuropathogenesis Division - animal models of human prion diseases</gtr:description><gtr:id>AD97CA35-5B4D-4FC2-A0BC-3C9C39F20C1A</gtr:id><gtr:impact>Scientific publications</gtr:impact><gtr:outcomeId>oddTJSPUgj7-1</gtr:outcomeId><gtr:partnerContribution>Collaboration and access to anmal models to study human prion diseases</gtr:partnerContribution><gtr:piContribution>Provision of tissue from cases of human prion disease, along with genetic, clinical and epidemiological data for the establishment and investigation of animal models of human prion diseases in the Neuropathogeneis Division, Roslin Intitute, Edinburgh.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>31888839-E095-417F-B354-76BFB603C89C</gtr:id><gtr:impact>150 members of the public and interested professionals attended an invited public lecture I delivered as part of the Summer 2010 meeting of the Pathological Society of Great Britain in the University of St Andrews

None</gtr:impact><gtr:outcomeId>fuD3eZXNpW7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish TSE Network Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>149DFDA9-4F4E-45AB-9699-DF1F8BD76F7D</gtr:id><gtr:impact>The Symposium was entitled &amp;quot;Is Alzheimer's Disease a Transmissible Disease&amp;quot; and my presentation wasentitled &amp;quot; Alzheimer's disease: Is there any evidence for human to human transmission? A Pathologist's view&amp;quot;.

Renewed calls for research into the pathophysiology of Alzheimer's disease, using human tissue samples from brain banks</gtr:impact><gtr:outcomeId>PcpUV5aeZSj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>169456</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>60CB210E-A7B8-474B-95D1-F4FF704A9CC8</gtr:id><gtr:outcomeId>98EDB7D56AD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in the CJD Incidents Panel and ACDP TSE Working Group, both of which are national advisory committees to the UK Government.</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>0DA22855-918D-4784-ADCB-E795FA1B303B</gtr:id><gtr:impact>Modifies policy on clinical matters relating to CJD, infection control policy and the identification and management of patients &amp;quot;at risk&amp;quot; of any form of CJD.</gtr:impact><gtr:outcomeId>ELDPqnrHM1T</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Infectivity in vCJD tissues</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A984B11F-3C41-4FCB-AD6E-3F520E5482BA</gtr:id><gtr:impact>Health and Saefty Guidlines for those working with TSE tissues in laboratories or patients in a clinical setting</gtr:impact><gtr:outcomeId>3B53E7A3479</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ACDP TSE Risk Assessment Subgroup</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>897D4BAD-6B9B-4C71-BE12-3A0F6B391BF6</gtr:id><gtr:impact>Influences DH policy on measures to understand the epidemiology of vCJD infection, and to reduce the secondary spread of vCJD in the UK.</gtr:impact><gtr:outcomeId>KMf4JesD2Dy</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Sporadic and variant CJD brain tissue samples</gtr:description><gtr:id>4DB77755-AC57-44FB-91D4-28417292D851</gtr:id><gtr:impact>Publications, many of which are listed in the publications section of this return</gtr:impact><gtr:outcomeId>280E3CAA0B6</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Reference materials supplies to WHO and to NIBSC</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A range of novel anti-prion protein antibodies, some of which appear to be specific for the diseqse-associated form of prion protein.</gtr:description><gtr:id>1D3B3DE1-C000-4C07-A829-C432EB4D24E2</gtr:id><gtr:impact>Scientific publication and possible patent</gtr:impact><gtr:outcomeId>BCH57MY1gzu</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Anti-prion protein antibodies</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>25B3B02B-3445-41A4-B1D2-5B829357FD0B</gtr:id><gtr:title>The molecular epidemiology of variant CJD.</gtr:title><gtr:parentPublicationTitle>International journal of molecular epidemiology and genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d56e231d3af9ca04ec0b456c175491bf"><gtr:id>d56e231d3af9ca04ec0b456c175491bf</gtr:id><gtr:otherNames>Mackay GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1948-1756</gtr:issn><gtr:outcomeId>PP6YWWShoFg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>150E23AB-BAC7-43A6-99C3-894328D5DD4E</gtr:id><gtr:title>Transplantation of ocular tissue from a donor with sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; experimental ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb7426edb632ee5399bf187b2d76a4d2"><gtr:id>eb7426edb632ee5399bf187b2d76a4d2</gtr:id><gtr:otherNames>Tullo AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1442-6404</gtr:issn><gtr:outcomeId>1AFE7AE9363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93E2E751-450F-41C0-AE01-70EAB87AF0B3</gtr:id><gtr:title>An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>F12914458F3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00EA09F5-7EBA-4109-BDF3-0E785CACA9C2</gtr:id><gtr:title>Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/beb95ebb21fcd54384b2e59882c8d9ea"><gtr:id>beb95ebb21fcd54384b2e59882c8d9ea</gtr:id><gtr:otherNames>Concha-Marambio L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>58ac54389ba933.42425322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AE99EF4-CB4E-4BE6-A764-7F18C6CB3707</gtr:id><gtr:title>Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d01be4e5ebcfec24b2e66bf35579f82"><gtr:id>4d01be4e5ebcfec24b2e66bf35579f82</gtr:id><gtr:otherNames>Uro-Coste E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5235449B2A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24778FD7-934C-4601-87B5-246646284384</gtr:id><gtr:title>Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dac2d08588f2437846bb06495fe403c0"><gtr:id>dac2d08588f2437846bb06495fe403c0</gtr:id><gtr:otherNames>Heath CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5E88A8B5907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E7BD9B8-311D-41E5-BE41-516DA2D8C3EC</gtr:id><gtr:title>A case of protease sensitive prionopathy in a patient in the UK.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>shRXefNTCMQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24C309AB-B5C0-4B2D-9260-CCE7F314F056</gtr:id><gtr:title>Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0224a5b82887b2ff861c7e49a8edd715"><gtr:id>0224a5b82887b2ff861c7e49a8edd715</gtr:id><gtr:otherNames>Choi YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>54452feec048f3.84348347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF611241-AE92-491B-A55C-89A15813A2ED</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.</gtr:title><gtr:parentPublicationTitle>Haemophilia : the official journal of the World Federation of Hemophilia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1351-8216</gtr:issn><gtr:outcomeId>E4EA1F5811D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A393550-CF13-4FBF-8745-0A5364E280E3</gtr:id><gtr:title>Relative Abundance of apoE and A?1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48df2869b0ba296c7ba8136a5487142b"><gtr:id>48df2869b0ba296c7ba8136a5487142b</gtr:id><gtr:otherNames>Moore RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>585d36272ee3b6.58532793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBB8A038-F1EC-456F-8EB0-D6326ADECC8F</gtr:id><gtr:title>Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Str&amp;auml;ussler-Scheinker disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3cd41808812882abfbd34ec82d751c75"><gtr:id>3cd41808812882abfbd34ec82d751c75</gtr:id><gtr:otherNames>Sikorska B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>88C09125CC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>138F77C9-4437-4E6D-A9A1-D65F5547BC8C</gtr:id><gtr:title>Biology and neuropathology of prion diseases.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>E68CE2786E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAA16567-226A-484C-AE11-3CD30641695B</gtr:id><gtr:title>The contribution of different prion protein types and host polymorphisms to clinicopathological variations in Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>pm_13686_26_22374623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE7E376C-036A-4DEB-ADB8-23158B85647D</gtr:id><gtr:title>Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>3015C125F5A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95155C92-934A-426E-9A83-13FCAF377BD5</gtr:id><gtr:title>Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c21ca207c819acc81fdee427916113"><gtr:id>07c21ca207c819acc81fdee427916113</gtr:id><gtr:otherNames>Gill ON</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_13686_26_24129059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>926C026F-073C-45F0-AC20-20E9D4A85F5F</gtr:id><gtr:title>Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f636933e7908d6d1aee348f4477bb4f"><gtr:id>5f636933e7908d6d1aee348f4477bb4f</gtr:id><gtr:otherNames>Urwin P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5a956c3c2ca367.22601619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39E7D259-9763-422C-91B1-CB5D6BDDA4D3</gtr:id><gtr:title>A case of variably protease-sensitive prionopathy treated with doxycyclin.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd73d19d7892a165f5a4cde0b5b81a6b"><gtr:id>fd73d19d7892a165f5a4cde0b5b81a6b</gtr:id><gtr:otherNames>Assar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5a956c3ccbf564.63907003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25878080-0450-420C-890C-F777DE15BC80</gtr:id><gtr:title>Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>24059357728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA2F61B1-E70F-40C4-A691-869EFC00DC07</gtr:id><gtr:title>A Naturally Occurring Bovine Tauopathy Is Geographically Widespread in the UK.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4dc600f7d8b2e3a9ea1c7b4a990a8c3"><gtr:id>a4dc600f7d8b2e3a9ea1c7b4a990a8c3</gtr:id><gtr:otherNames>Jeffrey M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a956c3d5621c1.99994807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BFEC419-8C19-4D4C-B438-A048814F353F</gtr:id><gtr:title>Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acf0ecdbbd10a5abf267a3eae39d2b5b"><gtr:id>acf0ecdbbd10a5abf267a3eae39d2b5b</gtr:id><gtr:otherNames>Yull HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>ED0893E38AF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>675D1DAA-1203-448C-BF1F-F0ABF172D33A</gtr:id><gtr:title>UNRAVELLING THE MYSTERIES OF SPORADIC CJD</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad855d3a11f35d7fe7120091d806de71"><gtr:id>ad855d3a11f35d7fe7120091d806de71</gtr:id><gtr:otherNames>Mackay G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_13686_26_24108956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43CD5B67-57C6-406E-A404-0ACCA11E4DFC</gtr:id><gtr:title>Infectivity in bone marrow from sporadic CJD patients.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3183f67ce6affe36ca7e236285b3a469"><gtr:id>3183f67ce6affe36ca7e236285b3a469</gtr:id><gtr:otherNames>Huor A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>5a956c3bbd0f30.41883263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F66302C3-5BE1-4FE3-9DDE-10FFBB5F156B</gtr:id><gtr:title>Gerstmann-Str&amp;auml;ussler-Scheinker disease with atypical presentation.</gtr:title><gtr:parentPublicationTitle>BMJ case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a9356e6c82c2ff481cb580fe89220da"><gtr:id>4a9356e6c82c2ff481cb580fe89220da</gtr:id><gtr:otherNames>Keuss SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-790X</gtr:issn><gtr:outcomeId>5a956c3b609f11.70456736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1D0B4B7-6445-4FF6-A262-6D867F6CE8A5</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease: an update.</gtr:title><gtr:parentPublicationTitle>Folia neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1509-572X</gtr:issn><gtr:outcomeId>pm_13686_26_22505363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E30343B8-BA82-4D09-8F2C-F4D5E61C17ED</gtr:id><gtr:title>New lexicon and criteria for the diagnosis of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf772d1e7a35b539e3bd4a3241a5a017"><gtr:id>bf772d1e7a35b539e3bd4a3241a5a017</gtr:id><gtr:otherNames>Giaccone G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>djPo1RSnqK9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4911C15-9473-4A5A-874A-F3B1C9297863</gtr:id><gtr:title>The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de69946299c2a220e1c21b61b8f9f4cb"><gtr:id>de69946299c2a220e1c21b61b8f9f4cb</gtr:id><gtr:otherNames>Jansen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>tb7VeGd8hNA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C19EF90A-8AE4-4BC5-BE96-C79C3A6E4864</gtr:id><gtr:title>Molecular barriers to zoonotic transmission of prions.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f859b7503c4ec9d02a383748458878"><gtr:id>69f859b7503c4ec9d02a383748458878</gtr:id><gtr:otherNames>Barria MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>54462715de7486.56813778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9CE492B-CE6D-44DA-9031-F02FD453FB59</gtr:id><gtr:title>Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de69946299c2a220e1c21b61b8f9f4cb"><gtr:id>de69946299c2a220e1c21b61b8f9f4cb</gtr:id><gtr:otherNames>Jansen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>E87F0291F79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A09AC78E-4758-4A37-8712-13B2590D9D7C</gtr:id><gtr:title>Clusterin expression in follicular dendritic cells associated with prion protein accumulation.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcb9a592a95f7031a08f7d4cab6a3b97"><gtr:id>dcb9a592a95f7031a08f7d4cab6a3b97</gtr:id><gtr:otherNames>Sasaki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>34644B12641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97A108AD-FDD9-4710-823A-4AAB19D33E20</gtr:id><gtr:title>Size frequency distributions of the florid prion protein aggregates in variant Creutzfeldt-Jakob disease follow a power-law function.</gtr:title><gtr:parentPublicationTitle>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c51118a9b283eac54a22a4a597e497d3"><gtr:id>c51118a9b283eac54a22a4a597e497d3</gtr:id><gtr:otherNames>Armstrong RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1590-1874</gtr:issn><gtr:outcomeId>24A7CDCFF30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30F8ABD2-782C-442F-9105-FA5428D2FE71</gtr:id><gtr:title>Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0309a92237e73e96d878543f9439b59"><gtr:id>e0309a92237e73e96d878543f9439b59</gtr:id><gtr:otherNames>Orr? CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5a956c3b929837.91554162</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E39CC918-4452-4589-98CF-1495041AD3CC</gtr:id><gtr:title>UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>58ac543901eb98.14948501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84C3CB0D-5D6D-4D04-9D56-4710657131EE</gtr:id><gtr:title>Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ac5281be27a0dd6cc4b30f4c87e4a2"><gtr:id>85ac5281be27a0dd6cc4b30f4c87e4a2</gtr:id><gtr:otherNames>Petsch B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>dBAGgmEfNXk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>838EC6A8-D426-43FF-A3B4-BE346E7C5278</gtr:id><gtr:title>The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>doi_55f94594516bc693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC84CA63-8B1D-47DF-BD6E-A2456FCC6967</gtr:id><gtr:title>The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2ca9145f48adcb73e0b6ea59d85fe7"><gtr:id>af2ca9145f48adcb73e0b6ea59d85fe7</gtr:id><gtr:otherNames>Wiseman FK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5a956c3d262bd2.56466317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>591C263E-4C43-4A47-97F2-87F25BC26FFE</gtr:id><gtr:title>Sporadic Creutzfeldt-Jakob disease in two adolescents.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/529d4fdc4135233e93ee64653f334385"><gtr:id>529d4fdc4135233e93ee64653f334385</gtr:id><gtr:otherNames>Murray K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>F4283C0D8A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23C26F82-86A8-4BDE-93E5-64E3F3CBECB1</gtr:id><gtr:title>Human prion diseases and the risk of their transmission during anatomical dissection.</gtr:title><gtr:parentPublicationTitle>Clinical anatomy (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-3806</gtr:issn><gtr:outcomeId>54452ff0969fb9.61830512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE80756E-A159-4B94-926E-716E8A79D1B6</gtr:id><gtr:title>A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c51118a9b283eac54a22a4a597e497d3"><gtr:id>c51118a9b283eac54a22a4a597e497d3</gtr:id><gtr:otherNames>Armstrong RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5a956c450a7716.27571941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47DDE92-D5A4-46EE-822F-3794CA0C5652</gtr:id><gtr:title>Infective dementias.</gtr:title><gtr:parentPublicationTitle>Panminerva medica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0031-0808</gtr:issn><gtr:outcomeId>D76291B96D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F676D2E-00E4-4084-B557-EBDD35FC33A6</gtr:id><gtr:title>Prions in the urine of patients with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18bb8bd5a1ae8eaee9432b6e7f49a53"><gtr:id>a18bb8bd5a1ae8eaee9432b6e7f49a53</gtr:id><gtr:otherNames>Moda F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>54452fef618206.39982711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65E20ED8-D6DC-4E4C-AB4C-816156E39CC1</gtr:id><gtr:title>Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0224a5b82887b2ff861c7e49a8edd715"><gtr:id>0224a5b82887b2ff861c7e49a8edd715</gtr:id><gtr:otherNames>Choi YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>n95UULjy4Jt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA61DAEB-2B30-448D-84B4-95F1840BCDAA</gtr:id><gtr:title>vCJD and the gut: implications for endoscopy.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>1020FD81033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1A29C60-12E3-4C86-92CB-04E2A23AA6F5</gtr:id><gtr:title>Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8af9cf2f702036e3d9ad87d3260a56ed"><gtr:id>8af9cf2f702036e3d9ad87d3260a56ed</gtr:id><gtr:otherNames>Yokoyama T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>PtS94dwVy3w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D582F1-92DC-4440-B54A-409821D0B61A</gtr:id><gtr:title>No major change in vCJD agent strain after secondary transmission via blood transfusion.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>D8EC867A3A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7C999ED-6EFB-46E1-B742-D7A685A65220</gtr:id><gtr:title>Predicting susceptibility and incubation time of human-to-human transmission of vCJD.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>B5D731A2767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA468002-2E22-4A5E-81A9-9BA0CCBEB2DC</gtr:id><gtr:title>Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Transfusion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0041-1132</gtr:issn><gtr:outcomeId>0582EB27D04</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>438F3C9B-48BB-4A97-890B-21232282A86C</gtr:id><gtr:title>Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>NheBGTPsi2E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE9BB5E-9036-4893-8065-E6C7014AD4D2</gtr:id><gtr:title>Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0224a5b82887b2ff861c7e49a8edd715"><gtr:id>0224a5b82887b2ff861c7e49a8edd715</gtr:id><gtr:otherNames>Choi YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>gRoMYYMnAmF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25A2E117-414C-4CAA-B1F6-467A6767D11B</gtr:id><gtr:title>Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54452ff13c9ab2.12662698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3945911-E4D1-481C-BF48-80128C8AD358</gtr:id><gtr:title>Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03e8b39a903bf2641c971a207456f49d"><gtr:id>03e8b39a903bf2641c971a207456f49d</gtr:id><gtr:otherNames>Lourenco PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>797BD2D425B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EE81C04-B1E6-4741-A7A4-A22F24185CCE</gtr:id><gtr:title>Comparative Study of Prions in Iatrogenic and Sporadic Creutzfeldt-Jakob Disease.</gtr:title><gtr:parentPublicationTitle>Journal of clinical &amp; cellular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc8dc855a7c01c5ac3178caa93b7b86b"><gtr:id>dc8dc855a7c01c5ac3178caa93b7b86b</gtr:id><gtr:otherNames>Xiao X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5a956c3ddbae69.12074791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB5555BC-8C88-466F-A920-829354D32E20</gtr:id><gtr:title>A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Str&amp;auml;ussler-Scheinker disease phenotype: comparison with similar cases from the literature.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de69946299c2a220e1c21b61b8f9f4cb"><gtr:id>de69946299c2a220e1c21b61b8f9f4cb</gtr:id><gtr:otherNames>Jansen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>HovNiwsgQEX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94856AAA-D307-42A6-AE54-FE4DA5DA37FE</gtr:id><gtr:title>Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.</gtr:title><gtr:parentPublicationTitle>Haemophilia : the official journal of the World Federation of Hemophilia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a452b429825417f9eabe0604c692a9cf"><gtr:id>a452b429825417f9eabe0604c692a9cf</gtr:id><gtr:otherNames>Peden A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1351-8216</gtr:issn><gtr:outcomeId>efm8CKruSA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E906DCC2-830A-4450-A7F4-EC33029449BA</gtr:id><gtr:title>Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/913616637f3eacc218f43f5e3fd13245"><gtr:id>913616637f3eacc218f43f5e3fd13245</gtr:id><gtr:otherNames>Hizume M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a956c457f0293.32540012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5540DAA7-99A3-451B-AEC5-89D7D4C25255</gtr:id><gtr:title>Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1cdc869fdb7df38fa1e256edb618b6f"><gtr:id>c1cdc869fdb7df38fa1e256edb618b6f</gtr:id><gtr:otherNames>Parchi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_13686_26_22744790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66DD137B-274B-4FCF-B17C-EDB58819155E</gtr:id><gtr:title>Application of Atomic Dielectric Resonance Spectroscopy for the screening of blood samples from patients with clinical variant and sporadic CJD.</gtr:title><gtr:parentPublicationTitle>Journal of translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36f2ad2a9be8fae4682dcf916c8762d0"><gtr:id>36f2ad2a9be8fae4682dcf916c8762d0</gtr:id><gtr:otherNames>Fagge TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1479-5876</gtr:issn><gtr:outcomeId>F7A3B15EE3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDCFB4AD-1F59-4F13-80DD-0B22150612FF</gtr:id><gtr:title>Differential protein profiling as a potential multi-marker approach for TSE diagnosis.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d7d1b6de444e5c1b0d8e94f8fa93124"><gtr:id>4d7d1b6de444e5c1b0d8e94f8fa93124</gtr:id><gtr:otherNames>Barr JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>jBwncnqWQb5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1100ADD6-B4DF-4B37-B35D-2C8454ED9CF9</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Haemophilia : the official journal of the World Federation of Hemophilia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1351-8216</gtr:issn><gtr:outcomeId>ACyncwnHhqF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11C82761-0B5D-41D3-BC1F-5975844F074E</gtr:id><gtr:title>RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a981970c0bb3133c99817ae65ec291d"><gtr:id>6a981970c0bb3133c99817ae65ec291d</gtr:id><gtr:otherNames>Sherwood KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>SX1f4MGTZW8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A73E5E5D-334A-4ADB-B9B8-72C25EE0D8D1</gtr:id><gtr:title>Familial prion disease with a novel serine to isoleucine mutation at codon 132 of prion protein gene (PRNP).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54bcf5c0c5f7ea69089734b89fb8662a"><gtr:id>54bcf5c0c5f7ea69089734b89fb8662a</gtr:id><gtr:otherNames>Hilton DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5a956c45320779.19455509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3951B1E3-8C38-4D51-859C-EAFFC7A2A507</gtr:id><gtr:title>Amyloid-? accumulation in the CNS in human growth hormone recipients in the UK.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5a732690da2944.83654891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5568E98-0623-47A8-84C3-E5C29984D0B6</gtr:id><gtr:title>Investigation of variant Creutzfeldt-Jakob disease implicated organ or tissue transplantation in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c4e3b3cd3b5715bd3fc2e4295b75b6"><gtr:id>f0c4e3b3cd3b5715bd3fc2e4295b75b6</gtr:id><gtr:otherNames>Molesworth A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>54452ff05d8977.26351167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EDDDF19-0E46-47B5-ACDE-D268215D1044</gtr:id><gtr:title>Dementia with Lewy bodies associated with ataxia, myoclonus, and cortical blindness.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90e65cba6627e4797ac896340a44b100"><gtr:id>90e65cba6627e4797ac896340a44b100</gtr:id><gtr:otherNames>Hindle JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_13686_26_20310054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30DB306F-1B10-4FA5-A506-67B2BAD8ACD1</gtr:id><gtr:title>Exploring the zoonotic potential of animal prion diseases: in vivo and in vitro approaches.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f859b7503c4ec9d02a383748458878"><gtr:id>69f859b7503c4ec9d02a383748458878</gtr:id><gtr:otherNames>Barria MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>54452ff10ae558.09829506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C09361ED-3759-4D20-AE5B-C07A782C2639</gtr:id><gtr:title>Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13686_26_23449776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA2EEED4-FA98-4C82-945B-A74E53068E04</gtr:id><gtr:title>Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60dc254158d22ff0ccd17fa994121d19"><gtr:id>60dc254158d22ff0ccd17fa994121d19</gtr:id><gtr:otherNames>Clewley JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>A3F2EDF1093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DA637F4-F0C0-4327-B4AB-B08E2386A9A2</gtr:id><gtr:title>Brain banking for neurological disorders.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_13686_26_24074724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFB02E92-EBFE-4CD7-9A20-3074F9948F82</gtr:id><gtr:title>Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blot.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0224a5b82887b2ff861c7e49a8edd715"><gtr:id>0224a5b82887b2ff861c7e49a8edd715</gtr:id><gtr:otherNames>Choi YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>VNZJNwT94DE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85FA9021-15EA-488F-B814-BE9CFFEFBC44</gtr:id><gtr:title>Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dac2d08588f2437846bb06495fe403c0"><gtr:id>dac2d08588f2437846bb06495fe403c0</gtr:id><gtr:otherNames>Heath CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>VPpUCquFG5T</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B34F0E5-9245-46C7-8C8E-6ACD5A2FCABD</gtr:id><gtr:title>Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b86cec0b6d39932d5af0dec99ddf53b8"><gtr:id>b86cec0b6d39932d5af0dec99ddf53b8</gtr:id><gtr:otherNames>Bell JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>6DF3E0F87A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56DFF569-F5AB-45B6-9BDD-075A9C95AE11</gtr:id><gtr:title>Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ae1aa01433ba23d09fb7de58f533706"><gtr:id>7ae1aa01433ba23d09fb7de58f533706</gtr:id><gtr:otherNames>Newman PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54452ff0cae036.79639044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E21E59C2-5616-42C1-92D5-C291E990CC68</gtr:id><gtr:title>-glycosylation and expression in human tissues of the orphan GPR61 receptor.</gtr:title><gtr:parentPublicationTitle>FEBS open bio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fcd3f0052e649cbd5d4366cbcd90f8c"><gtr:id>2fcd3f0052e649cbd5d4366cbcd90f8c</gtr:id><gtr:otherNames>Kozielewicz P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2211-5463</gtr:issn><gtr:outcomeId>5a2fdbc76649d2.81568520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E2EA358-CA95-4681-BD57-97B50F5A87F6</gtr:id><gtr:title>Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d54e0f74c95125e20ee2238719dac20"><gtr:id>3d54e0f74c95125e20ee2238719dac20</gtr:id><gtr:otherNames>Douet JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5a31d94c7c1735.95870580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02C5457-E6A5-48F2-B081-F0AB59C74E01</gtr:id><gtr:title>Sporadic and Infectious Human Prion Diseases.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5cc148a1af756621f53e2c335b8d343"><gtr:id>c5cc148a1af756621f53e2c335b8d343</gtr:id><gtr:otherNames>Will RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>58ac54392b07e2.70692692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>268648BD-521A-463B-A29F-A1AD16460497</gtr:id><gtr:title>Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a5f35c9fa20b489d4081690465b1418"><gtr:id>3a5f35c9fa20b489d4081690465b1418</gtr:id><gtr:otherNames>Takeuchi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>585d5a4d7b3cb8.83876824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60E9E426-8368-4520-83E9-CC3D3545DA72</gtr:id><gtr:title>Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>06FB43E3B6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A62D3DD-5809-42EC-89DA-653CE2E81E00</gtr:id><gtr:title>Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>qVJfznoVyzy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E86B92B-DDAF-47E2-A32B-E5E789A5AD63</gtr:id><gtr:title>Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cdb00a3df43e8f580a15e4469167a51"><gtr:id>0cdb00a3df43e8f580a15e4469167a51</gtr:id><gtr:otherNames>Vanni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn><gtr:outcomeId>5a956c3ac0b6e5.40447180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>876DCE73-B617-43B3-BEA4-FB2769A0D354</gtr:id><gtr:title>Molecular model of prion transmission to humans.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>NxtVEd5TfZ4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FFE7F30-7D1C-440D-BCCD-070182CC3CC7</gtr:id><gtr:title>The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium.</gtr:title><gtr:parentPublicationTitle>Experimental gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c1fc934b985e758bb1c8ed68a940aae"><gtr:id>5c1fc934b985e758bb1c8ed68a940aae</gtr:id><gtr:otherNames>Alafuzoff I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0531-5565</gtr:issn><gtr:outcomeId>pm_13686_26_22705312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>084CBCA0-BC07-4526-9635-49576CC06B6D</gtr:id><gtr:title>vCJD prion acquires altered virulence through trans-species infection.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8085e58ad0688084bd88795edbb9e8d"><gtr:id>f8085e58ad0688084bd88795edbb9e8d</gtr:id><gtr:otherNames>Asano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>4706F9928E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01D88DF1-C8B4-4DBE-B153-129AC44A9583</gtr:id><gtr:title>Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc79d7f51ba018a88e83e29ce38e29bc"><gtr:id>dc79d7f51ba018a88e83e29ce38e29bc</gtr:id><gtr:otherNames>Krejciova Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>pm_13686_26_24183781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E95D6D0-5251-4EA9-BB40-9513D5C9EC7C</gtr:id><gtr:title>Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_13686_26_22394291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>866C76D0-FF43-4C30-A0F8-734EBB245F86</gtr:id><gtr:title>Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5a956c3db23895.70104382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B54837C-9A40-4DCB-ACCD-26322B900512</gtr:id><gtr:title>Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease transmission.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>Kb9zdkzwQhx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FAD85E2-993B-42F4-9951-A5F1F57A85EE</gtr:id><gtr:title>Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1cdc869fdb7df38fa1e256edb618b6f"><gtr:id>c1cdc869fdb7df38fa1e256edb618b6f</gtr:id><gtr:otherNames>Parchi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>AAFA81B1D8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A98E9C00-1D05-4D43-BACB-85BF2DFC8FD6</gtr:id><gtr:title>Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bb1df96eb6c522533fcf07eeb565f27"><gtr:id>4bb1df96eb6c522533fcf07eeb565f27</gtr:id><gtr:otherNames>Fairfoul G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>58ac5439537314.23547349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F74CE98-B8B7-49AB-83B5-168902078A63</gtr:id><gtr:title>Variant CJD. 18 years of research and surveillance.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>54452fefb90b51.83719848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0DF89B1-E392-41BD-9101-0B9C361B890F</gtr:id><gtr:title>Sporadic Creutzfeldt-Jakob disease: discrete subtypes or a spectrum of disease?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>TgwnHbxsstH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>199743CC-D324-41F2-AC26-154FFBA4B440</gtr:id><gtr:title>In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>29EC4F50045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2B7CD26-5684-4144-BFB5-54D5AC290E01</gtr:id><gtr:title>Sporadic Creutzfeldt-Jakob disease presenting as progressive nonfluent aphasia with speech apraxia.</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9be49eefc2150e1f0bb017706484ad7"><gtr:id>f9be49eefc2150e1f0bb017706484ad7</gtr:id><gtr:otherNames>Kobylecki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>pm_13686_26_22732678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B70A62-2996-4C72-B3C9-5F1D053AAA25</gtr:id><gtr:title>No evidence of asymptomatic variant CJD infection in immunodeficiency patients treated with UK-sourced immunoglobulin.</gtr:title><gtr:parentPublicationTitle>Vox sanguinis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea848087eaa35b112ee09affa73b45e9"><gtr:id>ea848087eaa35b112ee09affa73b45e9</gtr:id><gtr:otherNames>Helbert MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0042-9007</gtr:issn><gtr:outcomeId>5a956c3c83aae7.84693503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6A9C3FD-68A3-4B20-9EAD-D89F7B93BED9</gtr:id><gtr:title>MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e98df31dd286214d8b1f0848de310ad0"><gtr:id>e98df31dd286214d8b1f0848de310ad0</gtr:id><gtr:otherNames>Petrovic IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_13686_26_23180183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81D4A56D-4674-466A-B5A2-F7F7EDA0C595</gtr:id><gtr:title>Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>DC4A2ACD58D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7423A72-9386-4E8A-8E25-066993D9212F</gtr:id><gtr:title>Ultrastructural characteristics (or evaluation) of Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies or prion diseases.</gtr:title><gtr:parentPublicationTitle>Ultrastructural pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/175e5c6df7a7443144b8fe3064c47a02"><gtr:id>175e5c6df7a7443144b8fe3064c47a02</gtr:id><gtr:otherNames>Liberski PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0191-3123</gtr:issn><gtr:outcomeId>tcBShHJpRr4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF2C2104-F2D1-478E-9EE8-3358B2E4D5F9</gtr:id><gtr:title>Genotype-dependent molecular evolution of sheep bovine spongiform encephalopathy (BSE) prions in vitro affects their zoonotic potential.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc79d7f51ba018a88e83e29ce38e29bc"><gtr:id>dc79d7f51ba018a88e83e29ce38e29bc</gtr:id><gtr:otherNames>Krejciova Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54452fef31ea83.13338810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F5F257C-A6F0-4EAA-8764-6A2A81B59AE2</gtr:id><gtr:title>Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc79d7f51ba018a88e83e29ce38e29bc"><gtr:id>dc79d7f51ba018a88e83e29ce38e29bc</gtr:id><gtr:otherNames>Krejciova Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>GrNsCLJ7Cca</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93638F05-7E58-43C8-B311-B75819CABAEE</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9222f98103cd41b8da5afdb06f61776"><gtr:id>b9222f98103cd41b8da5afdb06f61776</gtr:id><gtr:otherNames>Brandel JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>5a956c44d73946.96648754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>676B6EDD-4A9E-41B4-8AA1-514CC7DEF73D</gtr:id><gtr:title>Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425c10daa4923f9040e1a5332915e6e"><gtr:id>2425c10daa4923f9040e1a5332915e6e</gtr:id><gtr:otherNames>Kaski DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>maUjL82S8FN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C60D679-669A-408B-A8A1-A379D225418F</gtr:id><gtr:title>Further characterisation of the prion protein molecular types detectable in the NIBSC Creutzfeldt-Jakob disease brain reference materials.</gtr:title><gtr:parentPublicationTitle>Biologicals : journal of the International Association of Biological Standardization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acf0ecdbbd10a5abf267a3eae39d2b5b"><gtr:id>acf0ecdbbd10a5abf267a3eae39d2b5b</gtr:id><gtr:otherNames>Yull HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1045-1056</gtr:issn><gtr:outcomeId>5a956c433da772.34638686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28EC3BC9-4956-4BA6-972F-651FEB737521</gtr:id><gtr:title>Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, a synuclein and A? pathology.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>Vb6ngfwXzBE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B88FD658-3E08-44B2-B177-80E493EF9240</gtr:id><gtr:title>Differential overexpression of SERPINA3 in human prion diseases.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cdb00a3df43e8f580a15e4469167a51"><gtr:id>0cdb00a3df43e8f580a15e4469167a51</gtr:id><gtr:otherNames>Vanni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a956c3b38aa08.06891630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14F1639C-D5D5-4F42-ACC8-FE99D1F543BB</gtr:id><gtr:title>Pathological and biochemical investigation of a woman diagnosed with genetic Creutzfeldt-Jakob disease shortly after parturition.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5675dd974840a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9E20BDC-6FDE-4C5E-907D-9483B070D2D4</gtr:id><gtr:title>Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e90a2f64b84a8ace7f0bd4aa1ac943f5"><gtr:id>e90a2f64b84a8ace7f0bd4aa1ac943f5</gtr:id><gtr:otherNames>Goodall CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5AD0DA0AD11</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F993FE5-85A2-4CE6-A5A9-9800648093AB</gtr:id><gtr:title>Molecular pathology in neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Current drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1389-4501</gtr:issn><gtr:outcomeId>5a956c3e6d6955.00586931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A68ADC89-12A0-44A7-9709-4096DA254ACF</gtr:id><gtr:title>Human stem cell-derived astrocytes replicate human prions in agenotype-dependent manner.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc79d7f51ba018a88e83e29ce38e29bc"><gtr:id>dc79d7f51ba018a88e83e29ce38e29bc</gtr:id><gtr:otherNames>Krejciova Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a956c3b078e27.91835216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E45FC98A-2F5B-43C1-9C7F-824E966431A5</gtr:id><gtr:title>The application of in vitro cell-free conversion systems to human prion diseases.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>ozvBviARCyP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7288A5E0-D311-45D2-A88F-67A0D19DB561</gtr:id><gtr:title>Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders.</gtr:title><gtr:parentPublicationTitle>Haemophilia : the official journal of the World Federation of Hemophilia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d87d67c4bc7ac698d3b14f4866f73f1"><gtr:id>9d87d67c4bc7ac698d3b14f4866f73f1</gtr:id><gtr:otherNames>Millar CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1351-8216</gtr:issn><gtr:outcomeId>d8YivPjGxYh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD2FA654-5DC0-4F65-B19D-BB689FF60330</gtr:id><gtr:title>Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c1fc934b985e758bb1c8ed68a940aae"><gtr:id>5c1fc934b985e758bb1c8ed68a940aae</gtr:id><gtr:otherNames>Alafuzoff I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>54452feef01856.70832667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A77E51BE-CFE2-481B-8AB1-5AB2438E6D39</gtr:id><gtr:title>Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13686_26_23550113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D97CD17-C304-43D1-BA1C-E3493D303250</gtr:id><gtr:title>Gerstmann-Stra&amp;uuml;ssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54452ff02862c2.91672621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A90BF7B-B647-4C53-A552-BF7087B21A8E</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e806f798a88fb773892c475c32247cf3"><gtr:id>e806f798a88fb773892c475c32247cf3</gtr:id><gtr:otherNames>Ironside JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>57F514424CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B785010-D17C-4A33-B509-40267D1A7CA9</gtr:id><gtr:title>Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcf2e33875769f570dbfc57f0e704828"><gtr:id>bcf2e33875769f570dbfc57f0e704828</gtr:id><gtr:otherNames>Armitage WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>5a956c42e64ec9.10196639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B704CC8-26E6-411E-8656-C085C12182D5</gtr:id><gtr:title>Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wild-type mice.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>BBfJKDacaLX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>235CED09-03F1-46BE-92F7-3D3E887B4E4B</gtr:id><gtr:title>The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48df2869b0ba296c7ba8136a5487142b"><gtr:id>48df2869b0ba296c7ba8136a5487142b</gtr:id><gtr:otherNames>Moore RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>585d5352cc31f7.80666694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>200446A3-824B-4126-8817-E078719BCCCD</gtr:id><gtr:title>Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40fc0363daa5a951e8f3d157f455f35"><gtr:id>f40fc0363daa5a951e8f3d157f455f35</gtr:id><gtr:otherNames>Cescatti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>58ac6135bca587.40305327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7349458E-25B9-439F-AE1F-E02B4CBCAEF8</gtr:id><gtr:title>Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin.</gtr:title><gtr:parentPublicationTitle>Transfusion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc4c58d9e84539274a9200be96bf52cd"><gtr:id>dc4c58d9e84539274a9200be96bf52cd</gtr:id><gtr:otherNames>Oshita M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0041-1132</gtr:issn><gtr:outcomeId>58ac61361cd5e6.55260990</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900580</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>